Dash is a transformative Bioanalysis CRO which uses tech and automation to cut timelines from months to days while delivering unprecedented quality.

Dash Bio is a CRO on a mission to accelerate the process by which drugs are developed. Traditional bioanalysis is slow, manual and error‑prone. Dash changes the equation as the only tech-first bioanalysis partner, putting both speed and quality at the forefront. Processing every sample on an automated platform, they eliminate variability and delays, delivering high quality, GLP-compliant results for preclinical and clinical studies in days, not months. Dash provides ELISA/MSD, LC‑MS and qPCR assays across a wide range of biomatrices, sample prep methods and customization options, enabling sponsors to move from insight to action, faster. Co-founded by industry veterans who understand the pain of the traditional CRO model, Dash's model prioritizes transparency, publishing pricing upfront and backing every project with guaranteed timelines and outcomes.